SCHEMBL5161996

SCHEMBL5161996

Cc1nc(N(C)Cc2ccccc2)sc1-c1ccnc(Nc2ccc(N3CCN(CC=O)CC3)cc2)n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.63
CDK2 P24941 14/20 0.52
CCNE1 P24864 3/20 0.52
CDK9 P50750 13/20 0.51
CDK4 P11802 12/20 0.51
AURKA O14965 10/20 0.51
AURKB Q96GD4 10/20 0.51
CDK7 P50613 7/20 0.51
WEE1 P30291 5/20 0.51
CDK1 P06493 5/20 0.51
ALK Q9UM73 4/20 0.51
CDK6 Q00534 5/20 0.49
CCNT1 O60563 5/20 0.49
FLT3 P36888 4/20 0.49
CCND1 P24385 4/20 0.49
CCND3 P30281 4/20 0.49
CHEK1 O14757 3/20 0.49
DAPK3 O43293 3/20 0.49
JAK2 O60674 3/20 0.49
PRKD3 O94806 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4162362 0.87 CDK2 (0.69) GSK3BCDK2CCNE1CDK9CDK4
SCHEMBL5161475 0.85 GSK3B (0.72) GSK3BCDK2CCNE1CDK9CDK4
SCHEMBL5161282 0.84 CDK2 (0.56) GSK3BCDK2CCNE1CDK9CDK4
SCHEMBL6209137 0.83 CDK2 (0.74) GSK3BCDK2CCNE1CDK9CDK4
SCHEMBL5161995 0.83 GSK3B (0.69) GSK3BCDK2CCNE1CDK9CDK4
SCHEMBL5160844 0.82 CDK2 (0.72) GSK3BCDK2CCNE1CDK9CDK4
SCHEMBL5596571 0.82 GSK3B (0.75) GSK3BCDK2CCNE1CDK9CDK4
SCHEMBL28765373 0.81 GSK3B (0.54) GSK3BCDK2CCNE1CDK9CDK4
SCHEMBL5159297 0.80 CDK2 (0.75) GSK3BCDK2CCNE1CDK9CDK4
SCHEMBL5161340 0.79 CDK2 (0.57) GSK3BCDK2CCNE1CDK9CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756098-A2 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Cyclacel Limited (GB) 2007-02-28 EP claimed
WO-2005116025-A2 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS CYCLACEL LIMITED (GB) 2005-12-08 WO claimed
EP-1756098-A2 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Cyclacel Limited (GB) 2007-02-28 EP disclosed
WO-2005116025-A2 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS CYCLACEL LIMITED (GB) 2005-12-08 WO disclosed